National and Kapodistrian University of Athens
Χημειοπροφύλαξη στον καρκίνο: μετα-ανάλυση κλινικών δοκιμών και επιδημιολογικών μελετών παρατήρησης
Abstract
dc:descriptionChemoprevention is an innovative area of cancer research that focuses on the prevention of cancer through pharmacological, biologic, and nutritional interventions. Over the past two decades, a great effort has been made for the clinical development of chemopreventive agents and this effort continues to identify and develop new opportunities in prevention. The aim of this study was to make a contribution to the cancer chemoprevention research. In this effort, we used the methodology of meta-analysis. Meta-analysis is a quantitative approach for systematically combining the results of previous research in order to arrive at conclusions about the body of research. Studies of a topic are first systematically identified. Criteria for including and excluding studies are defined, and data from the eligible studies are abstracted. Last, the data a statistically, yielding a quantitative estimate of the size of the effect of treatment and a test of homogeneity in the estimate of effect size. We attempted to answer the following questions: 1 a. Do NSAIDs affect the risk of developing ovarian cancer? b. Does paracetamol affect the risk of developing ovarian cancer? 2 a. Use of statins and overall cancer risk. b. Use of statins and risk of breast cancer. c. Use of statins and risk of respiratory cancer. d. Use of statins and risk of haematological malignancies. e. Use of statins and risk of colorectal cancer. f. Use of pravastatin and risk of cancer among elderly patients. Our study provided suggestive evidence for a potential role of paracetamol in the primary prevention of ovarian cancer. None of the other studies supported a potential role of an agent (aspirin, NSAIDs, statins) in cancer chemoprevention. On the contrary, our findings suggest that pravastatin use may be associated with an increased risk of cancer among elderly individuals. Despite the “negative” results, the effort for clinical development of chemopreventive agents must continue. Cancer is ultimately the end stage of a chronic disease process characterized by abnormal cell and tissue differentiation. This process, which eventually leads to the final outcome of invasive and metastatic cancer, is carcinogenesis. We need to focus more effort on the control of carcinogenesis, rather than attempting to cure the end-stage disease. Thus, the common sense tells us that it is easier to fix anything when the smallest number of its components is broken. Chemopreventive agents appear thus far to have efficacy in several tumor types, and we hope to define their future role in treating and preventing other cancers in high-risk individuals. With the increasing understanding of the molecular processes involved in carcinogenesis, will helpfully come intervention modalities to prevent, reverse, or delay invasive cancer. Continued commitment to cancer prevention will significantly reduce the economic and medical burden of cancer.
Degree
thesis:*- Grantor dc:publisher
- National and Kapodistrian University of Athens
- Year dc:date
- 2007
Author and committee
dc:creator, dc:contributor.*- Authors dc:creator
-
- Bonovas, Stefanos
- Μπονόβας, Στέφανος
Subjects
dc:subject × 16Rights
- Language dc:language
- gre
Identifiers
dc:identifier.*- Identifier
- 10.12681/eadd/23585